Product and variants
CJC-1295 + Ipamorelin
5 mg + 5 mg
CJC-1295 + Ipamorelin batch WM-Z6U4-CP10
Variant-linked analytical facts transcribed from the original COA PDF files. This page applies only to the batch and variants named below.
Reported 29 Sept 2026 · Received 20 Sept 2026 · Record verified 29 Sep 2026
Reported purity
99.80% / 99.99% · RP-HPLC (220 nm)
Reported identity
LC-MS · Not stated
Original source documents
Each link below is kept beside the exact variant named in the source record.
5 mg + 5 mgCJC1295 without DAC / Ipamorelin · WM-Z6U4-CP10Purity 99.80% / 99.99% · RP-HPLC (220 nm) · Identity LC-MSOpen original COA PDF
Interpretation boundary
Chromatographic purity and mass-spectrometry identity answer different analytical questions. These results do not alone establish sterility, endotoxin status, fill quantity, stability, protocol suitability, or safety for human or animal use.
Source status
Published PDFs are supplier or manufacturer documentation. They are not presented as independent or accredited laboratory reports unless the PDF itself identifies the testing laboratory and accreditation.
Record history
— Batch, dates, purity and methods verified against the PDF currently published at each linked URL.